|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,423.50 GBX | +1.50% |
|
-0.32% | +5.50% |
| 09:09pm | Britain's life sciences plan gets mixed reception from pharma industry | RE |
| 08:32pm | FDA staff raises efficacy concerns for Otsuka's PTSD combination treatment | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.50% | -0.32% | -4.38% | +5.57% | +5.50% | -5.36% | -18.23% | -30.28% | -17.80% | 7.6TCr | ||
| +2.53% | +0.24% | -2.33% | +7.33% | +2.17% | -16.23% | +145.13% | +378.04% | +804.86% | 69TCr | ||
| +6.48% | +5.19% | +5.91% | +6.81% | +13.67% | +8.86% | -5.65% | +10.14% | +62.59% | 37TCr | ||
| +2.19% | -0.36% | -0.48% | +10.64% | +6.89% | +12.26% | +26.99% | +90.09% | +171.38% | 33TCr | ||
| +0.12% | -2.13% | -12.95% | +2.93% | -30.54% | -55.30% | +2.59% | +101.65% | +115.51% | 30TCr | ||
| +0.31% | -1.58% | -2.66% | +0.59% | +0.16% | -1.16% | -22.22% | -24.68% | -9.42% | 26TCr | ||
| -1.17% | -2.62% | -1.43% | +5.01% | +7.09% | -3.95% | +15.69% | +15.27% | -6.41% | 23TCr | ||
| -0.30% | +0.77% | -3.48% | +1.83% | -0.25% | -13.70% | -5.89% | +18.07% | +140.79% | 22TCr | ||
| +0.70% | -2.01% | +1.32% | +7.28% | -17.54% | -34.61% | -11.17% | +3.31% | +39.46% | 20TCr | ||
| +1.25% | -0.36% | -0.03% | +4.54% | +13.36% | -11.31% | +21.17% | +15.78% | +81.22% | 16TCr | ||
| +0.59% | -3.13% | +1.47% | +12.34% | -6.68% | -16.07% | -51.21% | -30.45% | -29.46% | 14TCr | ||
| +1.08% | -2.79% | -0.68% | +4.96% | +19.17% | +53.66% | +80.76% | +43.63% | -7.38% | 14TCr | ||
| +0.69% | -2.45% | +3.62% | -3.84% | +16.03% | -4.45% | +63.34% | +60.81% | +248.95% | 12TCr | ||
| +0.60% | -0.14% | -3.12% | -7.95% | -11.24% | -9.49% | -16.68% | -10.46% | -15.78% | 12TCr | ||
| +1.35% | -1.41% | -3.43% | -4.80% | -16.92% | +14.05% | -36.28% | -20.79% | -32.27% | 9.45TCr | ||
| -0.72% | -1.48% | -8.81% | +2.44% | -2.84% | +8.21% | +83.59% | +25.37% | +347.37% | 7.57TCr | ||
| +2.97% | +4.29% | +21.87% | +92.86% | +97.56% | +74.57% | - | - | - | 6.4TCr | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 6.37TCr | ||
| 0.00% | +7.15% | +6.18% | +18.54% | +24.66% | +40.31% | +53.65% | -33.33% | +339.35% | 5.32TCr | ||
| -1.57% | -0.41% | +0.60% | +5.17% | +4.64% | +1.79% | +9.68% | +17.51% | -29.58% | 4.71TCr | ||
| Average | +0.89% | -0.08% | -0.15% | +9.07% | +6.57% | +2.22% | +18.63% | +34.98% | +122.41% | 18.75TCr | |
| Weighted average by Cap. | +1.45% | -0.41% | -1.18% | +6.58% | +2.32% | -5.85% | +33.15% | +92.34% | +215.54% |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition